Tech Company Acquirers
ImmunoVaccine Technologies
Immunotope was purchased by ImmunoVaccine Technologies, a leading biopharmaceutical company, based in Halifax NS.
Company Overview
Company Name
ImmunoVaccine Technologies
Company Status
Out of Business
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
1819 Granville Street 303
Halifax NS, B3J 3R1
Canada
Halifax NS, B3J 3R1
Canada
Phone
Website
Email Address
Company Background Information
Overview
ImmunoVaccine Technologies Inc. (IVT) is a vaccine enhancement company focused on the commercialization of its patented VacciMax platform. VacciMax is a novel technology that can aid the development of new vaccines in human health applications with potential for both therapeutic cancer applications and preventative infectious disease vaccines.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/10/2007
Acquisitions By ImmunoVaccine Technologies
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randal Chase
Vice President
Brian Lowe
VP - Finance
Ron Smith
VP - R & D
Marc Mansour
Browse more tech company acquirers:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs